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Abstract 
Insulin-like growth factor (IGF) binding to IGF binding proteins is commonly assessed by adsorbing free IGF to albumin-coated 
charcoal and quantitating bound IGF in the supernatant, but the validity of this technique has been questioned and many variations have 
been described. We compared the measurement of binding affinity and capacity of purified IGFBPs 1-6 for IGF-II using charcoal 
adsorption and Superdex G75 high performance size exclusion chromatography (HPSEC) to separate free and bound 125I-IGF-II. Optimal 
HPSEC recovery and resolution was obtained for IGFBP-1 and IGFBP-6 with low salt buffer (0.1 M sodium phosphate, pH 7.4), whereas 
phosphate buffer supplemented with 0.5 M NaCI was optimal for IGFBPs 2-5. Measurement of binding of J25I-IGF-II to IGFBPs 3-5 
using the charcoal assay was also increased by the use of high salt buffer. Under optimal conditions, charcoal measurements of 
J25I-IGF-II binding to IGFBPs 1-5 were consistently lower than HPSEC measurements. By competitive binding using unlabeled IGF-II, 
the binding affinity of each of the IGFBPs for IGF-II was the same using both methods. Similarly, binding affinities as measured by 
charcoal assay were not affected by buffer composition. Differences in total binding obtained using the two methods and under different 
conditions were therefore due to differences in binding capacity. Charcoal adsorbs 15% of cross-linked 125I-IGF-II:IGFBP complexes 
which may partially explain the lower binding capacity for IGFBPs 1-5 determined by charcoal adsorption. Charcoal adsorption and 
HPSEC, therefore, are both valid methods for the measurement of binding affinities of IGFBPs for IGF-II, but assay conditions must be 
validated prior to measurement: of binding capacity. 
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1. Introduction 
Insulin-like growth factors (IGFs) bind with high affin- 
ity to a family of six specific binding proteins (IGFBPs) 
[1]. These binding proteins :modulate IGF activity [1-4]. In 
most circumstances they are inhibitory, but they may also 
potentiate IGF action. The IGFBPs share a number of 
properties. Their carboxyl- and amino-termini are substan- 
tially conserved. The IGFI3Ps bind IGF-I and IGF-II, but 
not the closely related pept:ide, insulin. However, the IGF- 
BPs differ in their regulation, distribution, binding affini- 
ties and specificities for IGF-I and IGF-II, allowing flexi- 
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ble regulation of IGF activity. Whereas IGFBPs 1-4 bind 
IGF-II with equal or slightly greater affinity than IGF-I, 
IGFBP-6 and IGFBP-5 bind IGF-II with 20- to 100-fold 
and ~ 7-fold greater affinity than IGF-I, respectively [1,5]. 
Recently, one of the most important areas of study in 
the IGF field has been determining how IGFBPs affect 
IGF actions. Particularly, attention has been focussed on 
the mechanisms whereby IGFBPs may either potentiate or 
inhibit IGF actions [6]. Factors that appear to be important 
include the molar ratio of IGF' IGFBP and the affinities 
with which IGFBPs bind IGFs. Thus, inhibition is favoured 
when IGFBP is present in excess concentration over IGF, 
whereas potentiation is favoured by a reduction of the 
binding affinity of IGFBPs for IGFs by post-translational 
mechanisms uch as proteolysis, dephosphorylation a d 
cell-association. Given that the kinetics of IGF:IGFBP 
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PII S0167-4889(96)00053-5 
80 L.A. Bach, M.M. Rechler / Biochimica et Biophysica Acta 1313 (1996) 79-88 
interactions appears to be important determinants of IGFBP 
action, precise measurement of parameters uch as the 
affinity constant and binding capacity is becoming more 
important. 
Many methods have been used for measurement of
IGFBP activity although few of them have been exhaus- 
tively validated for kinetic measurements. Perhaps the 
most widely-used method is Western ligand blotting, in 
which IGFBPs are separated on the basis of molecular 
weight by SDS-polyacrylamide g l electrophoresis, fol- 
lowed by transfer to nitrocellulose membranes, incubation 
with radiolabelled IGF and autoradiography [7,8]. This 
method is invaluable for detection of IGFBPs, but it is at 
best semiquantitative and measures binding of IGFs to 
IGFBPs bound to nitrocellulose, which may not reflect 
binding in solution. An example of the latter is in measure- 
ment of proteolyzed IGFBP-3 in pregnancy serum which 
no longer binds IGF as assessed by ligand blotting, but still 
binds as assessed by solution assays [9]. 
Immunological methods are useful for the specific iden- 
tification of individual IGFBPs. Immunobiotting is also 
semiquantitative. Radioimmunoassays have been devel- 
oped for specific IGFBPs but they cannot be used for the 
study of IGF:IGFBP binding kinetics or for measuring 
total IGF binding in a solution containing multiple IGF- 
BPs. Further, immunological methods may recognize dif- 
ferent forms of a specific IGFBP, such as intact and 
partially proteolyzed molecules, that may have widely 
differing binding affinities for IGFs and differing biologi- 
cal potencies [10]. 
A number of assays have been used to quantitatively 
measure the binding of IGFs to IGFBPs in solution. Fol- 
lowing incubation of radiolabled IGF with IGFBP, size 
exclusion chromatography is the reference method used to 
separate free and bound IGF [ 11,12], but it is time-consum- 
ing and therefore impractical for the processing of multiple 
samples. Adsorption of free 1GF with activated charcoal 
and quantitation of radioactivity in the supernatant (pre- 
sumably bound IGF) is simpler and quicker [8,11,12]. 
However, this method has been criticized as, in some 
circumstances, measurement of binding was found to be 
low [ 13], and it has been suggested that charcoal may sap  
IGF from IGF:IGFBP complexes during separation of free 
and bound ligand [14]. 
Many binding studies using charcoal have been per- 
formed on biological fluids or conditioned media that 
contain IGFBPs together with many other proteins and 
solutes. However, the validity of the charcoal adsorption 
method in the evaluation of binding to purified IGFBPs 
has not been demonstrated. Given the importance of accu- 
rate measurement of IGF binding to IGFBPs in the under- 
standing of the role of IGFBPs in IGF action, the present 
study determined optimal assay conditions and compared 
the assessment of IGF binding to individual purified IGF- 
BPs by high performance size exclusion chromatography 
(HPSEC) and charcoal assay. 
2. Materials and methods 
2.1. Materials 
Recombinant human ~25I-IGF-II (specific activity, 2000 
Ci/mmol) and 14C-labeled high molecular weight standard 
proteins were purchased from Amersham (Arlington 
Heights, IL). Recombinant human IGF-II for competitive 
binding studies was obtained from Upstate Biotechnology 
(Lake Placid, NY). Activated charcoal and fatty acid-free 
bovine serum albumin (BSA), which was used in the 
charcoal assays, were obtained from Sigma (St. Louis, 
MO). Radioimmunoassay grade BSA from Sigma was 
used in HPSEC buffers. Dulbecco's phosphate buffered 
saline (PBS) without calcium or magnesium was obtained 
from Mediatech (Herndon, VA). Disuccinimidyl suberate 
was purchased from Pierce (Rockford, IL). 
2.2. Methods 
2.2.1. Purification o f  IGFBPs 
IGFBP-1 from human amniotic fluid and rat IGFBP-2 
from media conditioned by BRL-3A rat liver cells (ATCC 
CRL 1442, generously provided by Dr. S. Peter Nissley, 
NCI) were purified by acid gel filtration, IGF-II affinity 
chromatography and reverse phase FPLC (ProRPC, Phar- 
macia, Piscataway, NJ) as previously described [5]. Their 
identities were confirmed by immunoreactivity with e~- 
6303, a monocional antibody against human IGFBP-1 
([15], generously provided by Dr. E.M. Rutanen, Minerva 
Medical Research Laboratory, Helsinki, Finland) and a- 
3695, a polyclonal antibody against rat IGFBP-2 [16], 
respectively. 
Recombinant glycosylated human IGFBP-3 expressed 
in Chinese hamster ovary cells was a gift from Dr. An- 
dreas Sommer (Celtrix, Santa Clara, CA [17]). Human 
IGFBP-4 purified from media conditioned by human T98G 
glioblastoma cells and recombinant human IGFBP-5 ex- 
pressed in Chinese hamster ovary cells [10] were gifts 
from Drs. David Clemmons and Ted Busby (Chapel Hill, 
NC). 
Human IGFBP-6 was purified from cerebrospinal fluid 
by IGF-II affinity chromatography and reverse phase FPLC 
(ProRPC, Pharmacia) as previously described [18] except 
that the acetonitrile gradient used for the last step was 
20-48% over 55 min. Identity was confirmed by amino 
acid composition and amino-terminal mino acid sequenc- 
ing [ 18]. 
2.2.2. Binding of  ~25I-IGF-H to IGFBPs 1 -6  
IGFBPs I -6  were incubated with 125I-IGF-II (~  20-30 
000 cpm, 12.5-18.8 pM) in low salt buffer (0.1 M NaPO 4 
buffer, pH 7.4, 0.1% BSA, 0.02% sodium azide) or high 
salt buffer (low salt buffer plus 0.5 M NaC1) in a final 
volume of 0.4 ml for 18 h at 4°C. Incubations were 
performed in 12 × 75 mm conical polystyrene tubes [Sars- 
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tedt (Newton, NC) or Labsource (Chicago, IL)]. Free and 
bound 125I-IGF-II were separated by charcoal adsorption or 
HPSEC as described below. 
2.2.3. High performance size exclusion chromatography 
(HPSEC) 
125I-IGF-II:IGFBP complexes and free ~25I-IGF-II were 
separated by Superdex Gq15 (Pharmacia) HPSEC using 
FPLC. The mobile phase was low or high salt buffer as 
described above (0.5 ml/rnin). In some early experiments 
with IGFBP-1 and IGFBF'-6, low salt buffer was Dul- 
becco's phosphate buffered saline (138 mM NaC1, 8.1 mM 
Na2HPO 4, 2.7 mM KC1, 1.2 mM KHzPO4)/0.05% 
Tween/0.02% sodium azide. For these IGFBPs, both 
buffers gave identical results. However, the Tween-con- 
taining buffer was unsatisfactory for other IGFBPs and 
was not subsequently used. The column was calibrated 
with dextran blue (MW 2 000 kDa, elution time 15 min), 
bovine serum albumin (68 kDa, 18 min), ovalbumin (43 
kDa, 20 min), cytochrorne C (12 kDa, 26 min), and 
lzsI-IGF-II (7.5 kDa, 29-30 min). Fractions (0.5 ml) were 
collected at room temperature and radioactivity quantitated 
in a V-counter (Beckman, Richmond, CA). IGF-II:IGFBP 
complexes (~ 30-40 kDa) eluted after 19-22 min. 
concentration 0.25 mM) for 30 min at 15°C. Cross-linking 
was terminated by incubation with 100 mM Tris/HC1 (pH 
7.5) for 5 min at 15°C. 
Cross-linked JzsI-IGF-II:IGFBP complexes were puri- 
fied by Superose-12 (Pharmacia) HPSEC under acid condi- 
tions. The mobile phase was 1 M acetic acid/0.1 M 
NaC1/0.1% BSA (0.5 ml/min). The column was cali- 
brated with dextran blue (mol wt 2000 kDa, elution time 
14 min), bovine serum albumin (68 kDa, 25 min), ovalbu- 
min (43 kDa, 29 min), cytochrome c (12 kDa, 34 min), 
and riboflavine (0.4 kDa, 45 min). Fractions (0.5 ml) were 
collected at room temperature and radioactivity quantitated 
in a V-counter. Separation of ~25I-IGF-II:IGFBP 2-6 com- 
plexes (elution time 28-30 min) from free 125I-IGF-II 
(elution time 45 min) was satisfactory. Separation of ~25I- 
IGF-II:IGFBP-1 complexes (elution time 34-35 min) from 
~25I-IGF-II was incomplete, so that fractions containing 
complexes were reapplied to the same column. 
To determine whether cross-linked ~25I-IGF-II:IGFBP 
complexes were adsorbed by charcoal, fractions containing 
complexes were dried by Speed-Vac (Savant, Farmingdale, 
NY) and reconstituted in 0.4 ml high or low salt charcoal 
assay buffer. The samples were then incubated with char- 
coal, centrifuged, and radioactivity counted as above. 
2.2.4. Charcoal binding assay 
Free t25I-IGF-II was removed by incubation with 0.5 ml 
ice-cold 5% charcoal/2% fatty acid-free BSA/0.02% Na 
azide in Dulbecco's phosphate-buffered saline (10 min, 
0°C), and centrifugation at 1300 g (20 min, 4°C). Radioac- 
tivity in supematants (thought o represent bound tracer) 
and charcoal precipitates (thought to represent free tracer) 
was quantitated by V-counting. 
2.2.5. Competitive binding studies 
To determine the effecl: of salt on binding affinity and 
apparent binding capacity of IGFBPs for IGF-II, IGFBPs 
1-6 were incubated with ~25I-IGF-II (~ 15-20000 cpm) 
and unlabelled IGF-II (5 pM-1.2 nM) in low or high salt 
buffer (18 h, 4°C). Bound and free ~25I-IGF-II were sepa- 
rated with activated charcoal as above, and radioactivity in
supematants was counted. 
To compare the estimation of binding affinities of IGF- 
BPs 1-6 for IGF-II by HPSEC and charcoal assay, IGF- 
BPs were incubated with 125I-IGF-II and unlabeled IGF-II 
(18 h, 4°C), following which bound and free 125I-IGF-II 
were separated either by HPSEC or with activated charcoal 
as described above. 
2.2.6. Affinity cross-linking 
IGFBPs 1-6  were incubated with 125I-IGF-II ( ,,, 2-4 × 
105 cpm) in 100 I~1 high or low salt buffer (4°C, 18h), 
after which 5 Ixl was taken for charcoal analysis and the 
remainder incubated with disucciminidyl suberate (final 
2.2.7. Charcoal adsorption of protein standards 
To determine whether charcoal adsorbs proteins of vari- 
ous molecular weights, ~4C-labeled proteins (20 txl diluted 
in 280 I~1 low salt buffer, ~ 28 ixg/protein) were applied 
to the Superdex G-75 column and eluted with low salt 
buffer. 14C-proteins (MW 20-200 kDa) eluted after 15-24 
rain. Fractions (0.5 ml) were collected and [3-radioactivity 
counted in 0.1 ml aliquots. Aliquots (0.3 ml) of each 
fraction were incubated with charcoal and centifuged as 
above, and B-radioactivity in the supernatants counted. 
After normalization of counts to the 0.5 ml volume of the 
fraction, the amount of protein adsorbed by charcoal was 
calculated as total radioactivity minus radioactivity remain- 
ing in the supernatant. 
2.3. Calculations 
Unless otherwise specified, incubation and HPSEC elu- 
tion buffers in a given experiment were the same. Follow- 
ing HPSEC, the fraction between the peaks of free and 
bound 125I-IGF-II with the fewest counts was determined; 
counts prior to and including this fraction were designated 
as bound, whereas ubsequent fractions were designated as 
free. The percentage of total counts bound by IGFBP was 
then calculated. Following charcoal separation, the per- 
centage of counts in the supernatant was also calculated. 
The relative percentage of binding as assessed by charcoal 
separation compared with HPSEC was then calculated. 
Results are shown as mean _+_ SD. 
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3. Results 
3.1. Establishing optimal charcoal and HPSEC assay con- 
ditions 
Prior to comparing the measurement of binding of 
J25I-IGF-II to IGFBPs by charcoal assay and HPSEC, the 
assumptions underlying each method were validated. 
Quantitative recovery of applied radioactivity and ade- 
quacy of resolution of free and bound ~25I-IGF-II by 
HPSEC were assessed. Completeness of adsorption of free 
I251-IGF-II by charcoal also was assessed. 
3.1.1. HPSEC 
1~5I-IGF-1I was incubated with IGFBPs 1-6 in low salt 
buffer, and free and bound tracer resolved by neutral 
Superdex G75 HPSEC in the same buffer. Approximately 
90% of the applied radioactivity was recovered for IGFBP- 
1 and IGFBP-6, ~ 70-85% for IGFBP-2, IGFBP-3 and 
IGFBP-4, and less than 50% for IGFBP-5. Although com- 
plexes of ~25I-IGF-II with IGFBP-1 and IGFBP-6 were 
effectively resolved in low salt buffer, IGFBP-2, -3, -4, or 
-5 were incompletely resolved from free 125I-IGF-II (il- 
lustrated for IGFBP-I and IGFBP-4 in Fig. I A and 1B, 
respectively). 
In order to improve recovery and peak resolution from 
the HPSEC column, 0.5 M NaCI was added to the elution 
buffer (high salt buffer). The addition of salt increased 
recovery of radioactivity for IGFBPs 2-5 to > 90%. 
Resolution of free and bound 125I-IGF-II was improved 
because J25I-IGF-II:IGFBP complexes eluted over fewer 
fractions, elution of free 125I-IGF-II was delayed by 1-2 
min, and there was little 'smearing' of tracer between the 
two peaks (Fig. 1B). Thus, optimal resolution and recovery 
by HPSEC were obtained using low salt buffer for IGFBP- 1 
and IGFBP-6, and high salt buffer for IGFBPs 2-5. 
3.1.2. Charcoal 
The basis of the charcoal separation assay is that free 
125I-IGF-II is quantitatively adsorbed to charcoal, whereas 
a25I-IGF-II bound to IGFBPs remains in the supernatant. 
First, we verified the completeness of adsorption of free 
125I-IGF-II by charcoal. A time-course study (not shown) 
demonstrated that 96-97% of IzsI-IGF-II was adsorbed 1 
min after charcoal addition using low or high salt incuba- 
tion buffers. A dose-response tudy (not shown) showed 
that maximal adsorption of ~25I-IGF-II was reached with 
25 ILl of charcoal, irrespective of the salt content of the 
incubation buffer. Under standard assay conditions (500 I, zl 
charcoal, 10 rain incubation), therefore, adsorption of free 
125I-IGF-II is essentially complete following incubation in 
high or low salt buffer. 
To verify that 125I-IGF-II was not being dissociated 
from IGF:IGFBP complexes during incubation with char- 
coal, IGFBP-3 was incubated with ~25I-IGF-II in high salt 
buffer for 18h at 4°C, following which ~25I-IGF-II:IGFBP-3 
A 
B 
12000 
10000 
8000 
z g 
6000 0 
4000 
2000 
0 
10 
10000 
20 30 40 
ELUTION TIME (min) 
z 
8OOO 
6000 
4000 
20OO 
• -A -~ 
01 - - ~ 20 
- - -vw 
30 40 
ELUTION TIME (rain) 
Fig. 1. High performance size exclusion chromatographic separation of 
free and bound 1251-IGF-II: (A) IGFBP-I was incubated with 125I-IGF-II 
(30000 cpm) in 0.4 ml low salt buffer as described in Section 2. Samples 
were applied to a Superdex G75 column and eluted with the same buffer 
(0.5 ml/min). Fractions were collected and 3'-radioactivity counted. 
Recovery of applied cpm from the column was 96%. (B) IGFBP-4 was 
incubated with t25I-IGF-II in high (filled circles) and low (open circles) 
salt buffer. Samples were applied to a Superdex G75 column and eluted 
with the same buffer. Recovery of applied radioactivity from the column 
was 99% with high salt buffer and 81% with low salt buffer. 
complexes were separated from free ~zsI-IGF-II by incuba- 
tion with charcoal/BSA for 10 sec, 1 min and 10 min 
prior to centrifugation. The amount of specifically bound 
125I-IGF-II after 10 rain was 105 _+ 5% (mean _+ SD, n = 3) 
of that at 1 min and 109_+ 14% (mean_+ SD, n = 3) of 
that at 10 sec, indicating that there was no time-dependent 
decrease in binding as would be anticipated if dissociation 
was occurring. Similar results were observed following 
binding in low salt buffer (results not shown). 
Further experiments were performed to study the effect 
of the amount of charcoal/BSA on measurement of 125I- 
IGF-II:IGFBP-3 complexes. 5 pA of charcoal/BSA proved 
inadequate for complete adsorption of free ~:5I-IGF-II 
following high or low salt incubation, as 17-40% of 
~2sI-IGF-II remained in the supernatant following incuba- 
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Table 1 
Comparison of the measurement of fzsI-IGF-II binding to purified human IGF binding proteins by HPSEC and charcoal binding assay 
83 
Charcoal/HPSEC (%) 
IGFBP-1 IGFBP-2 a IGFBP-3 IGFBP-4 IGFBP-5 IGFBP-6 
Low salt buffer b 94 + 5 (3) 67 5:7 (3) ¢ 55, 65 c.d 39 c.d _ c 112 5:22 (7) 
High salt buffer b 83 d 90 5:2 (3) 81 + 8 (5) 69, 83 d 45, 73 d 257 5:58 (3) 
Binding measured by charcoal is expressed as a percentage of binding measured by HPSEC in low and high salt conditions, respectively. Results show 
direct comparisons of charcoal and HPSEC in the same experiment. Results are expressed as mean + SD. The numbers in parentheses show the number of 
experiments u ed for the calculation (within each experiment, there were 1-4 charcoal replicates and 1-2 HPSEC replicates). 
a Rat IGFBP-2. 
b Low and high salt buffers as de,;cribed in Materials and methods. 
c Low recovery of applied radioactivity and incomplete resolution of bound and free tracer following HPSEC using low salt elution buffer may have 
adversely affected the accuracy of these values o they should be interpreted with caution. In the case of IGFBP-5, recovery of applied radioactivity was so 
low (47%) and resolution so inadequate under low salt conditions that measurement of binding was not possible. 
d Results are shown as individual values where fewer than 3 experiments were performed. 
tion in the absence of IGFBP. Following incubation in 
high salt buffer, the amount of specifically bound 125I-IGF- 
II with 500 Izl of charcoal/BSA was 93% and 86% of that 
with 100 pA in 2 separate xperiments. Similar results 
were observed following binding in low salt buffer (results 
not shown). These results indicate that there was little, of 
any, dose-dependent decrease in binding as would be 
anticipated if dissociation of IGF:IGFBP complexes was 
occurring. 
The above experiments iindicate that separation of bound 
and free ~25I-IGF-II is satisfactory using the standard 
conditions (500 txl charcoal, 10 min incubation) employed 
in the remainder of the study. 
3.2. Comparison of binding by charcoal and HPSEC under 
optimal conditions 
Having determined conditions for the optimal recovery 
and resolution of bound and free z25I-IGF-II by HPSEC 
and the completeness of free ~25I-IGF-II adsorption by 
charcoal, we next compared the binding of 125I-IGF-II to 
individual IGFBPs as assessed by charcoal adsorption or 
HPSEC under these optimal conditions. Tables 1 and 2 
respectively compare the ratio of charcoal/HPSEC mea- 
surements of binding under low and high salt conditions, 
and the ratio of low/high salt conditions with each separa- 
tion method, for all experiments in which these could be 
compared irectly. Results for IGFBP-2, -3, and -4 using 
low salt conditions in these Tables must be interpreted 
with caution as recovery of applied radioactivity and reso- 
lution of IGF:IGFBP complexes from free IGF were in- 
complete using HPSEC under these conditions. 
Using optimal buffers, binding of 125I-IGF-II to IGFBPs 
1-4 and IGFBP-6 as measured by charcoal was 69-112% 
of that measured by HPSEC (Table 1). Binding of z25I- 
IGF-II to IGFBP-5 as measured by charcoal was somewhat 
lower, although the exact extent was variable (45% and 
73% of the HPSEC measurements in two separate xperi- 
ments, Table 1). 
The effect of buffer composition on measurement of
~25I-IGF-II binding to IGFBPs using the charcoal assay 
was next determined. Salt concentration had little effect on 
~2sI-IGF-II binding to IGFBP-1 and IGFBP-2, but binding 
to IGFBPs 3-5 was increased and binding to IGFBP-6 
decreased in the presence of high salt buffer (Table 2). A 
similar comparison of salt effects on IGF-II binding using 
Table 2 
Effect of salt on measurement of t2sI-IGF-H binding to purified human IGFBPs by HPSEC and charcoal binding assay 
Low salt/high salt (%) 
IGFBP- 1 IGFBP-2 a IGFBP-3 IGFBP-4 IGFBP-5 IGFBP-6 
Charcoal assay 107, 116 b 113 + 18 (5) 74 + 13 (11) 45, 77 b 61, 73 b 165 + 20 (4) 
HPSEC 103 b 158 b.c 87, 51 b.c 81 b,c - ¢ 313 + 79 (3) 
Binding measured by HPSEC and charcoal in low salt conditions is expressed as a percentage of binding measured in high salt conditions. Results show 
direct comparisons of high and low salt conditions in the same experiment. Results are shown as mean + SD. The numbers in parentheses show the 
number of experiments u ed for the calculation (within each experiment, there were 1-4 charcoal replicates and 1-2 HPSEC replicates). 
a Rat IGFBP-2. 
b Results are shown as individual values where fewer than 3 experiments were performed. 
Low recovery of applied radioactivity and incomplete resolution of bound and free tracer following HPSEC using low salt elution buffer may have 
adversely affected the accuracy of these values o they should be interpreted with caution. In the case of IGFBP-5, recovery of applied radioactivity was so 
low (47%) and resolution so inadequate under low salt conditions that measurement of binding was not possible. 
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HPSEC could only be determined precisely for IGFBP-1 
and IGFBP-6, as the resolution and recovery of free and 
bound 125I-IGF-II after incubation with IGFBPs 2 -5  under 
low salt conditions were suboptimal. As determined by 
HPSEC, binding to IGFBP-1 was unaffected by salt con- 
centration whereas binding to IGFBP-6 was substantially 
decreased in the presence of high salt (Table 2). 
3.3. Binding affinities of IGFBPs for 1251-IGF-H using 
charcoal and HPSEC with high and low salt buffer 
3.3.1. Comparison of measurement of binding affinity of 
IGFBPs by HPSEC and charcoal assay 
Total binding of ]zsI-IGF-II reflects both the binding 
affinity of the IGFBP for ~25I-IGF-II and its binding 
capacity (i.e. the number of binding sites available to bind 
125I-IGF-II). We next compared the measurement of bind- 
ing affinity using HPSEC and the charcoal assay (Fig. 2). 
IGFBPs 1-6 were incubated with z25I-IGF-II and in- 
creasing concentrations of unlabeled IGF-I I  under the pre- 
viously determined conditions that were optimal for total 
binding to that IGFBP. Free and bound tracer were then 
separated by HPSEC or charcoal adsorption. Dose-depen- 
dent displacement of ]25I-IGF-II by unlabeled IGF-I I  was 
similar with both separation techniques, indicating that 
measurement of binding affinity is the same irrespective of 
the technique used for separation and that the charcoal 
assay is a valid method for estimating the binding affinities 
of IGFBPs for IGF-II. 
3.3.2. Influence of incubation buffer on binding affinity of 
IGFBPs for /25I-IGF-H as measured by charcoal adsorp- 
tion 
Since buffer composition affected total binding of ]251- 
IGF-I I  to IGFBPs, we also compared the binding affinities 
of IGFBPs for IGF-II  using low and high salt buffers in 
the charcoal assay. As estimated by the concentration of 
unlabeled IGF-I I  which decreased binding of 125I-IGF-II 
by 50%, the binding affinities of IGFBPs 1-6 for IGF-I I  
were unaffected by buffer composition (Fig. 3). Thus, 
although high salt buffer increased the specific binding of 
Iz~I-IGF-II to IGFBP-3, -4 and -5 and decreased specific 
binding to IGFBP-6 (Table 2), these differences do not 
reflect changes in binding affinity and so presumably 
reflect changes in apparent binding capacity. 
3.4. Adsorption of/25I-IGF-H:IGFBP complexes by char- 
coal 
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Fig. 2. Competitive inhibition of I-'51-IGF-II binding to IGFBPs 1-6 by 
unlabeled IGF-II as assessed by HPSEC (filled circles) and charcoal 
assay (open circles). 125I-IGF-II and IGFBP were incubated with increas- 
ing concentrations of unlabeled IGF-II. Bound and free 1251-IGF-II were 
separated by HPSEC or albumin-coated charcoal adsorption. Results are 
expressed as percentage of specific binding in the absence of unlabelled 
IGF-II. Non-specific binding, measured in the absence of IGFBP, was 
1-2% for HPSEC and charcoal adsorption. Each point was measured in
duplicate in the charcoal assay. A. IGFBP-1. Incubation and elution in 
low salt buffer. B o (HPSEC)= 64% (93 + 1% recovery for all HPSEC 
separations), B 0 (charcoal)= 56%. B. IGFBP-2. Incubation i  low salt 
and elution in high salt buffer (In this experiment, binding in high salt 
buffer was inexplicably ow, presumably due to experimental error. Since 
charcoal measurements of binding are similar egardless ofbuffer compo- 
sition (Table 2), the low salt values were substituted). B 0(HPSEC)= 69% 
(94+ 1% recovery), B 0 (charcoal)=60+ 1%. C. IGFBP-3. Incubation 
and elution in high salt buffer. B o (HPSEC)= 80% (94+5% recovery), 
B 0 (charcoal) =58 + 1%. D. IGFBP-4. Incubation and elution in high salt 
buffer. B 0 (HPSEC) = 87% (recovery 95 + 2%), B o (charcoal)= 72 + 1%. 
E. IGFBP-5. Incubation and elution in high salt buffer. B o (HPSEC)= 
74% (96 + 2% recovery), B0 (charcoal) =54 ± 2%. F. IGFBP-6. Incuba- 
tion and elution in low salt buffer. B o (HPSEC)= 26% (89+3% recov- 
ery), B 0 (charcoal) =37 ± 0%. 
Even under optimal conditions, charcoal measurements 
of 125I-IGF-II binding to IGFBPs 1-5 were consistently 
lower than HPSEC measurements (Table 1). Since the 
binding affinity measured by both methods was the same 
(Fig. 2), this difference in binding must have been due to 
differences in binding capacity. Erroneous estimates of 
binding capacity by charcoal assay may result from ad- 
sorption of some 125I-IGF-II:IGFBP complexes (in addi- 
tion to free 125I-IGF-II) by charcoal, or stripping of ]251- 
IGF-II  from complexes by charcoal as previously proposed 
[14]. 
To determine whether IGF: IGFBP complexes are ad- 
sorbed by charcoal, cross-linked complexes of 125I-IGF-II 
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and purified IGFBPs 1-6 were reconstituted in low salt 
(all IGFBPs) and high salt (IGFBPs 3-5)  buffers and 
incubated with charcoal suspension (Table 3). Surpris- 
ingly, charcoal adsorbed 11-19% of the cross-linked com- 
plexes containing IGFBPs 1-6. Buffer composition had 
little or no effect on the adsorption to charcoal of those 
complexes for which it could be measured: ~25I-IGF- 
II:IGFBP-3, 125I-IGF-II:IGFBP-4 or 125I-IGF-II:IGFBP-5. 
However, adsorption of IGF:IGFBP complexes by char- 
coal was not specific for the IGFBPs, as a similar propor- 
tion of the radioactivity in a series of ~4C-labeled proteins 
of molecular weight ~ 213,-200 kDa incubated with char- 
coal also was adsorbed (Table 3). 
The magnitude of the adsorption of t25I-IGF-II:IGFBP 
complexes to charcoal is sufficient to account for the 
difference between charcoal and HPSEC measurements of
binding under optimal conditions for IGFBP-1, IGFBP-3 
and possibly IGFBP-4 (Table 3). Although adsorption of 
~25I-IGF-II:IGFBP-5 complexes appears to only partially 
account for the disparity between charcoal and HPSEC 
measurements of binding, the magnitude of this difference 
was highly variable (55% and 27% in two experiments). 
The apparent inability of charcoal adsorption to account 
for the discrepancy between charcoal and HPSEC mea- 
surements of ~25I-IGF-II binding to IGFBP-2 is misleading 
because the experiment used the suboptimal low salt buffer 
which overestimates binding measured by HPSEC due to 
inadequate separation of free and bound tracer. 
Thus, adsorption to charcoal can account for the modest 
decrease in ~25I-IGF-II binding to some IGFBPs seen with 
charcoal compared with HPSEC, but can not explain the 
observed ifferences between high and low salt buffers. 
3.5. Basis for the lower binding of t25I-IGF-H to IGFBP-6 
with high salt buffer than low salt buffer 
Although a similar percentage of 125I-IGF-II:IGFBP-6 
complexes were adsorbed by charcoal as complexes con- 
taining other IGFBPs (Table 3), IGFBP-6 differed from the 
other IGFBPs in that binding of 125I-IGF-II was greater 
(especially in high salt buffer) when measured by charcoal 
than by HPSEC (Tables 1 and 2). To investigate the 
mechanism for this discrepancy, ~25I-IGF-II and IGFBP-6 
were incubated in high salt buffer, and free and bound 
125I-IGF-II separated using HPSEC (Fig. 4A). Equivalent 
samples were incubated with charcoal. Consistent with 
previous results (Table 1), binding as determined by char- 
coal was 259% of that determined by HPSEC. To confirm 
that all of the radioactivity in the charcoal supernatant 
represented IzsI-IGF-II:IGFBP-6 complexes, the super- 
natant was examined by HPSEC. Surprisingly, ~ 75% of 
the radioactivity in the charcoal supernatant eluted as free 
~25I-IGF-II (Fig. 4A). These results indicate either that free 
125I-IGF-II remains in the charcoal supernatant after incu- 
bation with IGFBP-6, or that some of the t25I-IGF- 
II:IGFBP-6 complexes in the supernatant dissociate during 
HPSEC. Since adsorption of free ~25I-IGF-II is quantitative 
in high or low salt buffer, dissociation is the likely expla- 
nation. Dissociation during HPSEC appears to be specific 
for complexes of 125I-IGF-II:IGFBP-6, as HPSEC analysis 
of charcoal supernatants following incubation of 125I-IGF-II 
and IGFBP-3 in high salt buffer indicated that only ~ 2% 
of the radioactivity eluted as free 125I-IGF-II (results not 
shown). 
Dissociation of IGF-II:IGFBP-6 complexes also oc- 
Table 3 
Adsorption of cross-linked 1251.-IGF-II:IGF binding protein complexes by charcoal 
Reconstitution % of cross-linked % by which charcoal 
buffer ~ complexes adsorbed binding is lower 
by charcoal than HPSEC b 
IGFBP-I low 11 + 1 (5) 6 + 5 (3) 
IGFBP-2 low 15 5:3 (6) 33 5:7 ¢ (3) 
IGFBP-3 low 13 5:1 (4) 
high 15 _ 3 (4) 19 5:8 (5) 
IGFBP-4 low 15, 16 a 
high 12 5:1 (3) 31, 17 a 
IGFBP-5 low 19 5:2 (3) 
high 14 5:1 (3) 55, 27 a 
IGFBP-6 low 12, 13 a - 12 + 22 (7) 
lac-proteins low 16 5:3 (10) 
(mol wt. ~ 20-200 kDa) 
I'5I-IGF-II:IGFBP complexes were covalently cross-linked with disucciminidyl suberate and separated from non cross-linked complexes and free 
~25I-IGF-II by Superose 12 H]I~SEC under acid conditions. Complexes were reconstituted with the stated buffer and incubated with charcoal suspension 
(0.5 ml, 10 rain on ice). f4C-molecular weight standard proteins were separated bySuperdex G75 HPSEC under neutral conditions. Results are shown as 
mean + SD. Number of obsep~ations areshown in parentheses. 
a low and high salt buffers as described inMaterials and Methods. 
b From Table 1. 
c This relatively large discrepancy between this figure and the percentage of 125I-IGF-II: GFBP-2 adsorption is probably due to inaccuracies in the 
estimation ofbinding of 125IGF-II to IGFBP-2 by HPSEC using low salt buffer. 
a Results are shown as individual values where only 2 measurements were made. 
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The initial studies describing IGF binding activity in 
serum, later attributed to IGFBPs, removed free IGF by 
charcoal adsorption [1 1,12]. The charcoal assay has been 
widely used for detecting IGF binding activity in biologi- 
cal fluids and cell culture media since that time. The 
present study was begun as part of a study comparing the 
relative affinities with which mutants of IGF-II bound to 
purified IGFBPs [5]. We have systematically compared the 
use of charcoal adsorption and HPSEC for the measure- 
ment of binding of 125I-IGF-II to purified IGFBPs. Al- 
though the salt content of buffers influenced binding mea- 
surements, the most striking conclusion from our results is 
that binding affinity as measured by charcoal or HPSEC 
was the same and was unaffected by buffer composition. 
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Fig. 3. Competitive inhibition of 125I-IGF-II binding to IGFBPs by 
unlabeled IGF-II as assessed by charcoal assay. J25I-IGF-II and IGFBP 
were incubated in low (open circles) and high (filled circles) salt buffer 
with increasing concentrations of unlabeled IGF-II. Free ]25I-IGF-II was 
adsorbed by albumin-coated charcoal and bound radioactivity was 
counted. Results are expressed as percentage of specific binding in the 
absence of unlabelled IGF-II. Non-specific binding, measured in the 
absence of IGFBP, was 2%. Each point is the mean of duplicate 
measurements. A. IGFBP-1. B 0 (low salt incubation buffer)= 57 + 1%, 
B 0 (high salt incubation buffer) = 49 + 1%. B. IGFBP-2. B 0 (low salt) = 
20+0%, B 0 (high salt) = 20+0%. C. IGFBP-3. B 0 (low salt) = 43 _ 1%, 
B 0 (high salt)= 74-+2%. D. 1GFBP-4. B 0 (low salt)= 44+ 1%, B 0 (high 
salt)= 58-+ 1%. E. IGFBP-5. B 0 (low salt)= 10+ 1%, B o (high salt)= 
38+3%. F. IGFBP-6 B 0 (low salt)= 36± 1%, B 0 (high salt)= 19-+ 1%. 
curred in low salt buffer although to a lesser extent (Fig. 
4B). When the charcoal supernatant was applied to the 
HPSEC column, ~ 25% of the radioactivity eluted as free 
'25I-IGF-II. Thus, with low salt buffer, the charcoal and 
HPSEC measurements of ]25I-IGF-II binding were similar 
(112 + 22%, Table 1) because the error introduced by the 
adsorption of t:5I-IGF-II:IGFBP-6 complexes by charcoal 
was offset by the quantitatively similar degree of dissocia- 
tion of IGFBP-6 complexes during HPSEC. Given the 
extensive dissociation of IGF:IGFBP-6 complexes during 
HPSEC, the charcoal assay is the preferred method for the 
measurement of binding to IGFBP-6. 
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Fig. 4. Binding of ]251-IGF-II to IGFBP-6 as measured by HPSEC. 
125I-IGF-II and IGFBP-6 were incubated in (A) high or (B) low salt 
buffer. Samples were applied to a Superdex G75 column and eluted with 
the same buffer (filled circles) or incubated with albumin-coated charcoal 
to remove free tracer. The supernatant was then applied to the column 
(open circles). Fractions were collected and 7-radioactivity counted. 
Recovery of applied radioactivity from the column was 87-96%. High 
salt: binding as determined by HPSEC was 16%, whereas binding as 
measured by charcoal was 42+ I%. Low salt: binding determined by 
HPSEC was 53%, whereas binding measured by charcoal was 59±0%. 
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However, the measurement of binding capacity, which is 
important for other studies such as the evaluation of 
stoichiometric relationship,; between IGFs and IGFBPs, 
was markedly affected by separation method and buffer 
composition. 
Although assessment of IGF binding by size exclusion 
chromatography has been regarded as the reference method, 
its use entails certain assumptions. Recovery of counts 
loaded onto the column must be close to complete to 
ensure accurate calculation of binding, and separation of 
bound and free ligand must be adequate. Resolution and 
recovery may be impaired because of electrostatic or hy- 
drophobic interaction of [igand and/or binding protein 
with the size exclusion column, resulting in peak broaden- 
ing or slow elution beyond the total volume of the column. 
Finally, the elution conditions hould not perturb binding 
equilibrium during the time taken for separation of bound 
and free ligand. We found that, using low salt elution 
buffer, recovery of applied radioactivity and resolution of 
bound and free tracer were satisfactory only following 
incubation of ~25I-IGF-II with IGFBP-1 and IGFBP-6. To 
improve recovery and separation of free and bound tracer 
following incubation of ~:~5I-IGF-II with IGFBPs 2-5, it 
was necessary to add 0.5 M NaC1 to the HPSEC elution 
buffer. Since 125I-IGF-II:IGFBP-6 complexes dissociated 
during HPSEC (especially using high salt buffer), the 
charcoal method is preferable to HPSEC for measurement 
of binding to this IGFBP. 
The validity of the ch~wcoal ssay depends upon char- 
coal adsorbing all of the fi'ee ligand and none of the bound 
ligand, and incubation with charcoal not perturbing the 
binding equilibrium. The. present study confirmed that 
these conditions are met. Charcoal adsorbs free ~25I-IGF-II 
rapidly and completely. Fo l l - "  ' • ~.5 vwmg incubation of I-IGF-II 
with IGFBP-3, addition of charcoal incubation buffer (0.5 
ml Dulbecco's phosphate buffered saline/0.02% sodium 
azide/2% BSA) without charcoal to the binding incuba- 
tion for 10 min did not alter binding as measured by 
HPSEC (data not shown), indicating that changes in vol- 
ume and buffer composition during incubation with char- 
coal do not alter binding. Finally, measurement of specific 
binding of ~25I-IGF-II to IGFBP-3 was independent of 
duration of incubation and amount of charcoal added, 
indicating that bound tracer was not dissociated uring 
incubation with charcoal. By comparison, incubation with 
charcoal/dextran results in dissociation of 3H-estradiol 
from its receptors in high salt buffer [19]. In that system, 
there was a dramatic decrease in specific binding with 
increasing time of incubation (~ 30% decrease from 5 to 
15 rain) or amount of charcoal (~ 85% decrease with 
5-fold increase in charcoal). 
Using optimal buffers, the binding affinities of IGFBPs 
1-6 for ~25I-IGF-II were the same when measured by 
charcoal or HPSEC. Additionally, binding affinities as 
measured by charcoal assay were unchanged by the salt 
content of the incubation buffer. By contrast, charcoal 
measurements of binding of ~25I-IGF-II to IGFBPs 1-5 
under optimal conditions were lower than measurements of 
binding using HPSEC. Since total binding reflects binding 
affinity and capacity, the difference in binding must have 
been due to alterations in binding capacity. 
Two possibilities that might explain this finding are 
adsorption of ~25I-IGF-II:IGFBP complexes by charcoal or 
stripping of ~25I-IGF-II from ~zsI-IGF-II:IGFBP complexes 
by charcoal. As described above, stripping of bound tracer 
is unlikely. Additionally, ~ 15% of IGF-II:IGFBP com- 
plexes were adsorbed by charcoal (Table 3). Adsorption 
did not depend on the composition of the incubation 
buffer. A similar percentage of other ~4C-labeled proteins 
was also adsorbed by charcoal, suggesting that this phe- 
nomenon is not specific for IGFBPs. Following correction 
for this non-specific adsorption to charcoal, measurements 
of binding using charcoal and HPSEC under optimal con- 
ditions were comparable for IGFBPs-1, -3, and -4. This 
was also true for IGFBP-6, although 125I-IGF-II may have 
dissociated from complexes during HPSEC making the 
latter measurements of binding less reliable. Adsorption 
was not measured for IGFBP-2 with the optimal high salt 
buffer, but it could be inferred that the 10% deficit in 
binding as measured by charcoal under those conditions 
(Table 1) might be accounted for by adsorption. Estimates 
of ~2sI-IGF-II binding to IGFBP-5 by charcoal assay re- 
mained slightly lower, although the difference between 
charcoal and HPSEC measurements was highly variable. 
Overall, adsorption of IGF-II:IGFBP complexes by char- 
coal could therefore xplain all or most of the discrepan- 
cies between charcoal and HPSEC measurements of bind- 
ing using optimal buffers, making it unnecessary to invoke 
the second explanation, stripping of ~25I-IGF-II from tzsI- 
IGF-II:IGFBP complexes. 
Our direct demonstration of adsorption of ~25I-IGF- 
II:IGFBP complexes by charcoal differs from the infer- 
ences by Unterman et al. [14] who compared binding of 
125I-IGF-II to normal rat serum (containing predominantly 
IGFBP-3) and diabetic rat serum (containing predomi- 
nantly IGFBP-1) by size exclusion chromatography and 
charcoal binding assay using low salt buffer. Assessment 
of binding to normal rat serum was similar by both meth- 
ods, but charcoal assay substantially underestimated bind- 
ing to IGFBPs from diabetic rat serum. As preincubation 
of serum from diabetic rats with charcoal did not affect 
subsequent binding of ~25I-IGF-I, the authors concluded 
that charcoal was stripping bound IGF rather than adsorb- 
ing IGFBP (and, by inference, IGF:IGFBP complexes). 
However, binding of ~25I-IGF-I to IGFBPs was essentially 
complete in these studies, suggesting that IGFBPs may 
have been present in excess. Under those circumstances, 
binding of ~25I-IGF-I to IGFBPs may have remained com- 
plete despite preadsorption of some IGFBP by charcoal. 
Thus, the inferences that adsorption did not occur and that 
stripping must have occurred is not proven by that study. 
Binding of 125I-IGF-II to IGFBP-3, 4 and 5 is lower, 
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and to IGFBP-6, higher, in low salt buffer when evaluated 
by charcoal assay. As this did not represent differential 
adsorption of IGF:IGFBP complexes to charcoal, it most 
likely reflected an effect on binding per se. [One would 
expect a similar alteration in binding evaluated by HPSEC, 
but it was not possible to accurately quantitate binding for 
these IGFBPs under low salt conditions because of poor 
separation of the bound and free radioactivity]. The addi- 
tion of NaCI to binding buffer also increased charcoal 
measurements of 125I-IGF-I binding to 30-150 kDa IGF- 
BPs in acid-stripped guinea pig serum (the 150 kDa peak 
presumably containing IGFBP-3) [20]. The authors at- 
tributed the increase to the uncovering of a high-affinity 
binding site, although interpretation of these results is 
complicated by the mixture of IGFBPs in serum. 
Buffer composition affects ligand binding in a number 
of systems in addition to IGF-II binding to IGFBPs. For 
example, the addition of NaC1 to incubation buffers affects 
binding of appropriate ligands to receptors for asialoglyco- 
proteins [21], dopamine [22], and opioids [23], and the 
addition of KCI affects binding to steroid receptors [19,24]. 
In some of these systems, the addition of salt to incubation 
buffers led to increased binding, whereas in others it led to 
decreased binding. The ionic strength of the buffer may 
alter the conformation of the binding protein [25] and 
thereby affect binding. In the case of progesterone r cep- 
tors, the presence of KC1 dramatically alters their structure 
by inducing dissociation of component subunits [24], but 
more subtle changes in conformation also may affect 
binding. Buffer composition also may affect binding by 
altering the conformation of the ligand. 
In summary, the present study demonstrates that mea- 
surement of the binding affinities of purified IGFBPs 1-6 
for IGF-II using the charcoal adsorption assay and are 
consistent with the results of the HPSEC reference method. 
However, measurement of binding capacity of particular 
IGFBPs may be affected by the separation method and by 
direct effects on binding, in part due to effects of buffer 
composition. Albumin-coated charcoal, in addition to 
rapidly adsorbing free 125I-IGF-II, also non-specifically 
adsorbs a small proportion of proteins of molecular mass 
20-200 kDa, including IGF:IGFBP complexes, indepen- 
dent of buffer composition. Adsorption can account for the 
difference in binding observed using the two mthods with- 
out needing to postulate 'stripping' of ligand from com- 
plexes by charcoal. Even with HPSEC, careful attention 
must be paid to elution conditions to ensure optimal 
separation and recovery. Dissociation of ligand from 
IGFBP-6 complexes was observed uring HPSEC separa- 
tion, especially under high salt conditions, making char- 
coal the method of choice to study IzsI-IGF-II binding to 
IGFBP-6. Accordingly, assay conditions must be validated 
prior to measurement of binding capacity using charcoal 
adsorption or HPSEC. This may be especially important 
for solutions containing mixtures of IGFBPs, as the con- 
tent of particular IGFBPs may be underestimated depend- 
ing on the conditions used. 
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